<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
<url>
  <loc>https://webnewsinsider.com/indias-nppa-slashes-137-cancer-drug-prices-by-up-to-96-saving-%e2%82%b93500-crore-annually/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-10T02:14:35+08:00</news:publication_date>
    <news:title>India’s NPPA slashes 137 cancer drug prices by up to 96%, saving ₹3,500 crore annually</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/fda-orders-class-wide-glp-1-label-update-for-rare-eye-disease-risk/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-10T00:21:16+08:00</news:publication_date>
    <news:title>FDA orders class-wide GLP-1 label update for rare eye disease risk</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/why-oncology-trials-chase-surrogate-endpoints-the-fda-ignores/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-09T23:22:29+08:00</news:publication_date>
    <news:title>Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/understanding-metastatic-prostate-cancer-prognosis-and-modern-treatment-pathways/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-09T09:11:34+08:00</news:publication_date>
    <news:title>Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/inside-abbvies-high-stakes-neuro-portfolio-and-pipeline-strategy/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-09T08:13:34+08:00</news:publication_date>
    <news:title>Inside AbbVie&#8217;s High-Stakes Neuro Portfolio and Pipeline Strategy</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/nangibotide-targets-acute-on-chronic-liver-failure-with-phase-2-data-due-2027/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-09T08:11:53+08:00</news:publication_date>
    <news:title>Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/how-ueno-banks-collapse-toppled-paraguays-president-and-shook-financial-trust/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-09T07:11:50+08:00</news:publication_date>
    <news:title>How Ueno Bank&#8217;s Collapse Toppled Paraguay&#8217;s President and Shook Financial Trust</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/why-insurers-send-their-own-nurses-to-deny-long-term-care-claims/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-09T01:23:07+08:00</news:publication_date>
    <news:title>Why Insurers Send Their Own Nurses to Deny Long-Term Care Claims</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/us-i-bonds-hit-5-51-rate-highest-fixed-component-in-two-decades/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-09T00:20:55+08:00</news:publication_date>
    <news:title>US I-Bonds Hit 5.51% Rate, Highest Fixed Component in Two Decades</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/sabr-versus-surgery-new-study-reveals-mortality-gap-for-early-stage-lung-cancer/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-08T11:23:18+08:00</news:publication_date>
    <news:title>SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/bristol-myers-squibb-vs-vertex-investment-merits-compared-ahead-of-2027/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-08T09:24:07+08:00</news:publication_date>
    <news:title>Bristol Myers Squibb vs Vertex: Investment Merits Compared Ahead of 2027</news:title>
  </news:news>
</url>
<url>
  <loc>https://webnewsinsider.com/the-1500-a-year-glp-1-drug-threat-to-retirement-savings/</loc>
  <news:news>
    <news:publication>
      <news:name>WebNewsInsider</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-11-08T05:12:57+08:00</news:publication_date>
    <news:title>The $1,500-a-Year GLP-1 Drug Threat to Retirement Savings</news:title>
  </news:news>
</url>
</urlset>